Operating cash flow decreased 23.0%
Operating cash flow changed -23.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow changed -23.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed -31.5% from the comparable as-filed period.
Operating income changed -488.9% from the comparable as-filed period.
Stock-based compensation changed +446.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed -209300 basis points from the comparable as-filed period.
Revenue changed -70.4% from the comparable as-filed period.
Capex / revenue changed +12091 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Research & development changed +242.3% from the comparable as-filed period.
Total assets changed +35.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Working capital changed +68.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current assets changed +27.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Shares outstanding changed -92.4% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.